Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Recommended Videos
It may seem that rabbits that walk with their hind legs over their head--like an acrobat walking on her hands--belong in a circus, but this breed spends almost all the time in a lab. By comparing these sauteur d’Alfort with run-of-the-mill breeds, researchers are learning what it takes to move limbs in a coordinated way. Now, they have pinned down the single genetic mutation that likely causes this peculiar form of locomotion.
WATCH NOWLike what you just watched? You can find similar content on the communities below.
Drug Discovery Genomics Research Proteomics & MetabolomicsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE